Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for EXHI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 0.00
January 31, 2026 0.00
October 31, 2025 0.00
July 31, 2025 0.00
April 30, 2025 0.00
January 31, 2025 0.00
October 31, 2024 0.00
July 31, 2024 0.00
April 30, 2024 0.00
January 31, 2024
October 31, 2023 0.1767M
July 31, 2023 -0.0112M
April 30, 2023 -0.0471M
January 31, 2023
October 31, 2022 0.1408M
July 31, 2022 -0.0817M
April 30, 2022 -0.1094M
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
Date Value
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Xcelerate, Inc. -0.0577M
Vivos Therapeutics, Inc. -3.148M
Hinge Health, Inc. 101.41M
Anika Therapeutics, Inc. -0.684M
Enovis Corp. 75.03M